{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:04:34Z","timestamp":1790697874248,"version":"4.1.0"},"reference-count":6,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of VitreoRetinal Diseases"],"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To describe methods for improving visualization of the port delivery system (PDS) with ranibizumab (Susvimo) during the refill-exchange procedure when visualization of the implant septum is compromised.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Multiple methods of PDS visualization using external illumination were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Transpupillary and transscleral illumination of the PDS reservoir body using various light sources improved visualization of the implant septum during the refill-exchange procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Indirect internal illumination of the PDS implant can facilitate visualization of the implant septum during the refill-exchange procedure, particularly when visualization is compromised by conjunctival edema, thickened Tenon capsule, or fibrous capsule formation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/24741264261484861","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:54:55Z","timestamp":1788782095000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Visualization Techniques for Port Delivery System Refill-Exchange"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8182-7731","authenticated-orcid":false,"given":"Mitchell T.","family":"Allphin","sequence":"first","affiliation":[{"name":"Tennessee Retina, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl C.","family":"Awh","sequence":"additional","affiliation":[{"name":"Tennessee Retina, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"Genentech Inc. A Member of the Roche Group. SUSVIMO (ranibizumab injection) Instructions for Use. Published online October 2021. Accessed March 21 2026. https:\/\/www.gene.com\/download\/pdf\/susvimo_prescribing.pdf"},{"issue":"7","key":"e_1_3_2_3_2","first-page":"6232","article-title":"Port delivery system with ranibizumab (PDS) stabilizes retinal nonperfusion and macular leakage: results from Pagoda and Pavilion phase 3 trials in diabetic macular edema (DME) and diabetic retinopathy (DR)","volume":"65","author":"Wirthlin R","year":"2024","unstructured":"Wirthlin R, Gill M, Howard D, Menezes A, Rahman S, Latkany P. Port delivery system with ranibizumab (PDS) stabilizes retinal nonperfusion and macular leakage: results from Pagoda and Pavilion phase 3 trials in diabetic macular edema (DME) and diabetic retinopathy (DR). Invest Ophthalmol Vis Sci. 2024;65(7):6232-6232.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.03.036"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2069301"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20220408-01"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20220412-01"}],"container-title":["Journal of VitreoRetinal Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264261484861","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/24741264261484861","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264261484861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:24:46Z","timestamp":1790695486000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/24741264261484861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":6,"alternative-id":["10.1177\/24741264261484861"],"URL":"https:\/\/doi.org\/10.1177\/24741264261484861","relation":{},"ISSN":["2474-1264","2474-1272"],"issn-type":[{"value":"2474-1264","type":"print"},{"value":"2474-1272","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"24741264261484861"}}